Abstract
Hepatitis in intrauterine and early postnatal life usually has different causes and clinical features than hepatitic processes experienced by older children and adults. Once obstruction has been excluded, neonatal hepatitis is the most common histologic pattern observed in cholestatic infants. The histologic features of neonatal hepatitis and hepatitis in early childhood are often significantly different from those observed in older patients. Because these features are by themselves frequently not diagnostic of any one liver disease, the pathologist must be familiar with all the potential causes and be able to suggest additional testing modalities, such as assays of metabolic enzymes, determination of specific metabolite levels or ultrastructural examina- tion, that may allow for a definitive diagnosis. In older chil- dren, the differential diagnosis of hepatitis overlaps to a greater extent with causes of hepatitis in adult patients. A detailed discussion of those conditions is beyond the scope of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown HL, Abernathy MP. Cytomegalovirus infection. Semin Perinato. 1998; 22: 260–266.
Becroft DM. Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect Pediatr Pathol 1981; 6: 203–241.
Kershisnik MM, Knisely AS, Sun CC, Andrews JM, Wittwer CT. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis. Hum Pathol 1992; 23: 1075–1080.
Chiu HH, Chang MH, Chen CL, Hsu HY, Ni YH. Case report: paucity of interlobular bile ducts in Chinese children. J astroenterol Hepatol 1996; 11: 434–438.
Dimmick JE. Intrahepatic bile duct paucity and cytomegalovirus infection. Pediatr Pathol 1993; 13: 847–852.
Kage M, Kosai K, Kojiro M, Nakamura Y, Fukuda S. Infantile cholestasis due to cytomegalovirus infection of the liver. A possible cause of paucity of interlobular bile ducts. Arch Pathol Lab Med. 1993; 117: 942–944.
Finegold MJ, Carpenter RJ. Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum Pathol. 1982; 13: 662–665.
Stone KM, Brooks CA, Guinan ME, Alexander ER. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis. 1989; 16: 152–156.
Singer DB. Infections of fetuses and neonates. In: Wigglesworth JS, Singer DB, eds. Textbook of Fetal and Perinatal Pathology. Maiden: Blackwell Science; 1998: 471–476.
Moore M. Centers for Disease Control. Enteroviral disease in the United States, 1970-1979. J Infect Dis. 1982; 146: 103–108.
Wang J, Atchison RW, Walpusk J, Jaffe R. Echovirus hepatic failure in infancy: report of four cases with speculation on the pathogenesis. Pediatr Dev Pathol. 2001; 4: 454–460.
Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis. 1983; 5: 1019–1032.
Chou LL, Chang CP, Wu LC. Neonatal coxsackievirus Bl infection associated with severe hepatitis: report of three cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1995; 36: 296–299.
Metzman R, Anand A, DeGiulio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr. 1989; 9: 112–114.
Silver MM, Hellmann J, Zielenska M, Petric M, Read S. Anemia, blueberry-muffin rash, and hepatomegaly in a newborn infant. J ediatr. 1996; 128: 579–586.
White FV, Jordan J, Dickman PS, Knisely AS. Fetal parvovirus B19 infection and liver disease of antenatal onset in an infant with Ebstein’s anomaly. Pediatr Pathol Lab Med. 1995; 15: 121–129.
Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet. 1996; 347: 868–869.
Dame C, Hasan C, Bode U, Eis-Hubinger AM. Acute liver disease and aplastic anemia associated with the persistence of B19 DNA in liver and bone marrow. Pediatr Pathol Mol Med. 2002; 21: 25–29.
Tung J, Hadzic N, Layton M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2000; 31: 557–561.
Sokal EM, Melchior M, Cornu C, et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet. 1998; 352: 1739–1741.
Strauss L, Bernstein J. Neonatal hepatitis in congenital rubella. A histopathological study. Arch Pathol. 1968; 86: 317–327.
Esterly JR, Slusser RJ, Ruebner BH. Hepatic lesions in the congenital rubella syndrome. J Pediatr. 1967; 71: 676–685.
Rosenberg HS, Oppenheimer EH, Esterly JR. Congenital rubella syndrome: the late effects and their relation to early lesions. Perspect Pediatr Pathol. 1981; 6: 183–202.
Duff P. Hepatitis in pregnancy. Semin Perinatol. 1998; 22: 277–283.
Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr. 1998; 133: 374–377.
Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J ediatr. 1987; 111: 34–39.
Granovsky MO, Minkoff HL, Tess BH, et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics. 1998; 102: 355–359.
Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine (Baltimore). 2002; 81: 260–269.
Bortolussi R. Neonatal listeriosis. Semin Perinatol. 1990; 14: 44–48.
Brooks SE, Audretsch JJ. Hepatic ultrastructure in congenital syphilis. Arch Pathol Lab Med. 1978; 102: 502–505.
Oppenheimer EH, Dahms BB. Congenital syphilis in the fetus and neonate. Perspect Pediatr Pathol. 1981; 6: 115–138.
Lynfield R, Guerina NG. Toxoplasmosis. Pediatr Rev. 1997; 18: 75–83.
Dische MR, Gooch WM III. Congenital toxoplasmosis. Perspect Pediatr Pathol. 1981; 6: 83–113.
Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002; 137: 947–954.
Gill RQ, Sterling RK. Acute liver failure. J lin Gastroenterol. 2001; 33: 191–198.
Ostapowicz G, Lee WM. Acute hepatic failure: a Western perspective. J astroenterol Hepatol. 2000; 15: 480–488.
Durand P, Debray D, Mandel R, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J ediatr. 2001; 139: 871–876.
Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis. 1996; 16: 349–355.
Whitington PF, Soriano HE, Alonso EM. Fulminant hepatic failure in children. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 63–88.
Scheuer PJ, Lefkowitch JH. Liver Biopsy Interpretation. Philadelphia, PA: WB Saunders; 2000: 134–150.
Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993; 105: 1824–1832.
Davies SE, Williams R, Portmann B. Hepatic morphology and histochemistry of Wilson’s disease presenting as fulminant hepatic failure: a study of 11 cases. Histopathology. 1989; 15: 385–394.
McCullough AJ, Fleming CR, Thistle JL, et al. Diagnosis of Wilson’s disease presenting as fulminant hepatic failure. Gastroenterology. 1983; 84: 161–167.
Goldfischer S, Grotsky HW, Chang CH, et al. Idiopathic neonatal iron storage involving the liver, pancreas, heart, and endocrine and exocrine glands. Hepatology. 1981; 1: 58–64.
Knisely AS, Magid MS, Dische MR, Cutz E. Neonatal hemochromatosis. Birth Defects Orig Artic Ser. 1987; 23: 75–102.
Knisely AS. Neonatal hemochromatosis. Adv Pediatr. 1992; 39: 383–403.
Wisser J, Schreiner M, Diem H, Roithmeier A. Neonatal hemochromatosis: a rare cause of nonimmune hydrops fetalis and fetal anemia. Fetal Diagn Ther. 1993; 8: 273–278.
Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr. 1998; 26: 85–89.
Muller-Berghaus J, Knisely AS, Zaum R, et al. Neonatal haemochromatosis: report of a patient with favourable outcome. Eur J Pediatr. 1997; 156: 296–298.
Knisely AS, O’Shea PA, Stocks JF, Dimmick JE. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J ediatr. 1988; 113: 871–874.
Oddone M, Bellini C, Bonacci W, Bartocci M, Torna P, Serra G. Diagnosis of neonatal hemochromatosis with MR imaging and duplex Doppler sonography. Eur Radiol. 1999; 9: 1882–1885.
Knisely AS. Iron and pediatric liver disease. Semin Liver Dis. 1994; 14: 229–235.
Jonas MM, Kaweblum YA, Fojaco R. Neonatal hemochromatosis: failure of deferoxamine therapy. J ediatr Gastroenterol Nutr. 1987; 6: 984–988.
Silver MM, Beverley DW, Valberg LS, Cutz E, Phillips MJ, Shaheed WA. Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies. Am J Pathol. 1987; 128: 538–554.
Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics. 2001; 108: 960–964.
Silver MM, Valberg LS, Cutz E, Lines LD, Phillips MJ. Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol. 1993; 143: 1312–1325.
Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and LaJSS-B ribonucleoproteins. Am J Dis Child. 1993; 147: 1072–1075.
Siafakas CG, Jonas MM, Perez-Atayde AR. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr. 1997; 25: 321–326.
Clayton PT. Delta 4-3-oxosteroid 5 beta-reductase deficiency and neonatal hemochromatosis. J Pediatr. 1994; 125: 845–846.
Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO. Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet. 1998; 351: 490–493.
Bove KE, Wong R, Kagen H, Balistreri W, Tabor MW. Exogenous iron overload in perinatal hemochromatosis: a case report. Pediatr Pathol. 1991; 11: 389–397.
Ruchelli ED, Uri A, Dimmick JE, et al. Severe perinatal liver disease and Down syndrome: an apparent relationship. Hum Pathol. 1991; 22: 1274–1280.
Taucher SC, Bentjerodt R, Hubner ME, Nazer J. Multiple malformations in neonatal hemochromatosis. Am J Med Genet. 1994; 50: 213–214.
Bale PM, Kan AE, Dorney SF. Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol. 1994; 14: 479–489.
Johal JS, Thorp JW, Oyer CE. Neonatal hemochromatosis, renal tubular dysgenesis, and hypocalvaria in a neonate. Pediatr Dev Pathol. 1998; 1: 433–437.
Verloes A, Lombet J, Lambert Y, et al. Tricho-hepato-enteric syndrome: further delineation of a distinct syndrome with neonatal hemochromatosis phenotype, intractable diarrhea, and hair anomalies. Am J Med Genet. 1997; 68: 391–395.
Dalhoj J, Kiaer H, Wiggers P, Grady RW, Jones RL, Knisely AS. Iron storage disease in parents and sibs of infants with neonatal hemochromatosis: 30-year follow-up. Am JMed Genet. 1990; 37: 342–345.
Kelly AL, Lunt PW, Rodrigues F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet. 2001; 38: 599–610.
Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991; 13: 372–374.
Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22: 696–699.
Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995; 19: 1409–1417.
Scheuer PJ, Maggi G. Hepatic fibrosis and collapse: histological distinction by orecin staining. Histopathology. 1980; 4: 487–490.
Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology. 2001; 120: 1828–1853.
Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990; 8(suppl): S18–S20; discussion S21-S23.
Jonas MM, Kelley DA, Mizerski J, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med. 2002; 346: 1706–1713.
Alward WL, McMahon BJ, Hall DB, Heyward WL, Francis DP, Bender TR. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis. 1985; 151: 604–609.
Beasley RP, Lin CC, Chien CS, Chen CJ, Hwang LY. Geographic distribution of HBsAg carriers in China. Hepatology. 1982; 2: 553–556.
Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975, 292: 771–774.
Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology. 1987; 92: 1844–1850.
McMahon BJ, Hoick P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001; 135: 759–768.
Hwang LY, Roggendorf M, Beasley RP, Deinhardt F. Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM. J Med Virol. 1985; 15: 265–269.
Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983; 147: 185–190.
Beath SV, Boxall EH, Watson RM, Tarlow MJ, Kelly DA. Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. BMJ. 1992; 304: 1169–1170.
Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med. 1996; 334: 1536–1537.
Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997; 26: 62S–65S.
Bortolotti F, Resti M, Giacchino R, et al. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J ediatr. 1998; 133: 378–381.
Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology. 2002; 36: S106–S113.
Ceci O, Margiotta M, Marello F, et al. High rate of spontaneous viral clearance in a cohort of vertically infected hepatitis C virus infants: what lies behind? J Hepatol. 2001; 35: 687–688.
Ceci O, Margiotta M, Marello F, et al. Vertical transmission of hepatitis C virus in a cohort of 2,447 HlV-seronegative pregnant women: a 24-month prospective study. J ediatr Gastroenterol. Nutr. 2001; 33: 570–575.
Committee on Infectious Diseases. America Academy of Pediatrics. Hepatitis C virus infection. Pediatrics 1998; 101: 481–485.
Jonas MM. Children with Hepatitis C. Hepatology 2002; 36: S173–S178.
Strickland DK, Riely CA, Patrick CC, et al. Hepatitis C infection among survivors of childhood cancer. Blood. 2000; 95: 3065–3070.
Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999; 341: 866–870.
Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood. 1997; 90: 4628–4633.
Guido M, Rugge M, Jara P, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology. 1998; 115: 1525–1529.
Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology. 1998; 28: 1416–1423.
Bichko V, Netter HJ, Wu TT, Taylor J. Pathogenesis associated with replication of hepatitis delta virus. Infect Agents Dis. 1994; 3: 94–97.
Bichko V, Netter HJ, Taylor J. Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. J irol. 1994; 68: 5247–5252.
Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med. 1997; 336: 347–356.
Di Bisceglie AM. Hepatitis G virus infection: a work in progress. Ann Intern Med. 1996; 125: 772–773.
Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 1996; 125: 740–743.
Bralet MP, Regimbeau JM, Pineau P, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 2000; 32: 200–204.
Kage M, Fujisawa T, Shiraki K, et al. Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology. 1997; 26: 771–775.
Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology. 1992; 15: 567–571.
Chu CM, Yeh CT, Sheen IS, Liaw YF. Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B. Gastroenterology. 1995; 109: 1926–1932.
Chu CM, Yeh CT, Chien RN, Sheen IS, Liaw YF. The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflect the level of viral replication in chronic hepatitis B virus infection. J lin Microbiol. 1997; 35: 102–105.
Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver. 1994; 14: 1–13.
White NJ, Juel-Jensen BE. Infectious mononucleosis hepatitis. Semin Liver Dis. 1984; 4: 301–306.
Maia DM, Garwacki CP. X-linked lymphoproliferative disease: pathology and diagnosis. Pediatr Dev Pathol. 1999; 2: 72–77.
Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol. 1996; 53: 111–115.
Albisetti M, Braegger CP, Stallmach T, Willi UV, Nadal D. Hepatic steatosis: a frequent non-specific finding in HIV-infected children. Eur J Pediatr. 1999; 158: 971–974.
Duffy LF, Daum F, Kahn E, et al. Hepatitis in children with acquired immune deficiency syndrome. Histopathologic and immunocytologic features. Gastroenterology. 1986; 90: 173–181.
Kahn E, Greco MA, Daum F, et al. Hepatic pathology in pediatric acquired immunodeficiency syndrome. Hum Pathol. 1991; 22: 1111–1119.
Jonas MM, Roldan EO, Lyons HJ, Fojaco RM, Reddy RK. Histopathologic features of the liver in pediatric acquired immune deficiency syndrome. J Pediatr Gastroenterol Nutr. 1989; 9: 73–81.
Resti M, Azzari C, Bortolotti F. Hepatitis C virus infection in children coinfected with HIV: epidemiology and management. Paediatr Drugs. 2002; 4: 571–580.
Bonacini M, Puoti M. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med. 2000; 160: 3365–3373.
Bierhoff E, Fischer HP, Willsch E, et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virch Arch. 1997; 430: 271–277.
Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997; 25: 541–547.
Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31: 929–938.
Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/ sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001; 33: 544–553.
Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis. 2002; 6: 335–346.
Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobil iary diseases: morphologic spectrum, clinical correlations and terminology. Liver. 1984; 4: 105–116.
Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996; 110: 848–857.
Devaney K, Goodman ZD, Ishak KG. Postinfantile giant-cell transformation in hepatitis. Hepatology. 1992; 16: 327–333.
Bernard O, Hadchouel M, Scotto J, Odievre M, Alagille D. Severe giant cell hepatitis with autoimmune hemolytic anemia in early childhood. J Pediatr. 1981; 99: 704–711.
Melendez HV, Rela M, Baker AJ, et al. Liver transplant for giant cell hepatitis with autoimmune haemolytic anaemia. Arch Dis Child. 1997; 77: 249–251.
Pilloni L, Lecca S, Van Eyken P, et al. Value of histochemical stains for copper in the diagnosis of Wilson’s disease. Histopathology. 1998; 33: 28–33.
Stricker BH, Blok AP, Claas FH, Van Parys GE, Desmet VJ. Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology. 1988; 8: 599–606.
Roy AK, Mahoney HC, Levine RA. Phenytoin-induced chronic hepatitis. Dig Dis Sci. 1993; 38: 740–743.
Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol. 1992; 9: 63–74.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ruchelli, E.D., Rand, E.B., Haber, B.A. (2004). Hepatitis and Liver Failure in Infancy and Childhood. In: Russo, P., Ruchelli, E.D., Piccoli, D.A. (eds) Pathology of Pediatric Gastrointestinal and Liver Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9066-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9066-2_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6492-7
Online ISBN: 978-1-4419-9066-2
eBook Packages: Springer Book Archive